Core Insights - The article highlights a significant decline in China's primary market financing events and amounts in 2024 compared to the previous year, indicating a challenging investment environment [2][6]. Financing Events Overview - In 2024, China experienced 9,054 financing events, a decrease of 2,528 events (22%) from last year [2][6]. - The total disclosed financing amount reached 626.11 billion RMB, down by 155.06 billion RMB (27%) year-on-year [2][6]. Industry Distribution - The top five industries for financing events accounted for 5,511 events (61% of total), including smart manufacturing, healthcare, artificial intelligence, materials, and enterprise services [7]. - The disclosed total amount for these industries was 255.85 billion RMB, representing 41% of the overall financing [7]. Regional Distribution - The leading regions for financing events were Jiangsu (1,576 events), Guangdong (1,491 events), Zhejiang (1,127 events), Shanghai (1,087 events), and Beijing (1,049 events) [10][11]. Stage Distribution - The majority of financing events were in the early stage, with 6,975 events (77.04%), followed by growth stage (1,742 events, 19.24%) and late stage (336 events, 3.72%) [12]. - In terms of disclosed financing amounts, early-stage financing accounted for 2,949.22 billion RMB (53.6%) [12]. IPO Market Analysis - In 2024, 227 Chinese companies completed IPOs, a 45% decrease from the previous year, raising a total of 129.79 billion RMB, down 65% year-on-year [4][53]. - The most active sector for IPOs was traditional industries, with 43 companies listed [54]. M&A Activity - There were 715 M&A events in China in 2024, a 38% decrease from last year, with a total disclosed amount of 234.90 billion RMB, down 52% [4]. Investment Institutions - A total of 3,551 VC/PE institutions participated in investments in 2024, a 23% decrease from the previous year [45]. - The top five VC/PE institutions by number of events were Shenzhen Capital Group (99 events), Zhongke Chuangxing (79 events), Qiji Chuangtan (69 events), Yida Capital (66 events), and Hefei Guoyao Capital (64 events) [46]. Unicorn Statistics - In 2024, 110 new unicorns were added globally, with 20 from China, accounting for 18% of the total [22]. - Currently, there are 1,874 unicorns worldwide, with 513 located in China, representing 27% of the total [23].

2025年3月30 日， 2025全球独角兽企业大会 即将盛大启幕， 思宇MedTech作为 宣传单位 ，诚挚邀请各行业领军企业、独角兽企业及有关机构参与本次大 会，大会将围绕新质生产力的构建和独角兽企业的创新发展， 共同探讨全球独角兽企业的成长路径与未来趋势，推动创新生态的构建与高质量发展 。对贵公 司的支持表示由衷的感谢！ 思宇MedTech补充说明： 独角兽指"成立不超过10年，估值达到10亿美金"的企业。但参会不完全受限于此条件， 具体请咨询工作人员，微信：suribot22 会议亮点： 现场将举行"中国独角兽企业"授牌仪式； 符合条件的企业可参与主题演讲、圆桌对话、北京市领导闭门会。 报名就有机会参加更多活动，包括： 1.参访重点特色中关村园区，与相关区政府深入对接； 2. 与北京市属产业投资基金 等重要投资机构开展融资对接交流， 3.与国企央企、大型科技企业等集团公司开展科研合作、应用场景对接。 提示： 本会议包括多个领域企业，医疗科技只是其中一部分。 补充提示： 这个会议无需企业付费，思宇也在协调由政府安排住宿。（企业请自行安排交通） 报名方式： 请复制以下链接到 IE 浏览器进行填写或点击文末 ...